Top Markets
Coin of the day
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Rang in Aktien #33463
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Aktienkurs
$0.5099
Zuletzt synchronisiert: 2024-10-15
Marktkapitalisierung
$7.60M
Veränderung (1 Tag)
2.02%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Anew Medical, Inc. (WENA)

Kategorie

EPS für Anew Medical, Inc. (WENA)
EPS zum June 2024 TTM: $0.00
Laut den aktuellen Finanzberichten und dem Aktienkurs von Anew Medical, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) $0.00. Am Ende des Jahres 2022 betrug das EPS $0.08 eine Steigerung gegenüber dem EPS von 2021, das $-0.09 betrug.
EPS-Verlauf von Anew Medical, Inc. von 2021 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) 0.00 -102.64%
2023 $0.14 69.29%
2022 $0.08 -196.73%
2021 $-0.09 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$17.32 -468,208.11%
US
$27.74 -749,829.73%
NL
- -
CH
- -
KR
$13.70 -370,372.97%
BE